🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Weihong Zhao

Yebio Bioengineering (China)

ORCID: 0009-0000-8422-9723

Also affiliated with Yancheng Institute of Technology

Immunology and MicrobiologyAgricultural and Biological SciencesEnvironmental ScienceMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

1in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology
Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 2 papers. Top paper: Results of a phase 1/2 study of sacituzumab tirumotecan in patients with unresectable locally advanced or metastatic solid tumors refractory to standard therapies.

23 citations

Jordi Rodon, Yan Liang, Xinhong Wu, Qun Li, Lihua Song +23 more

10 citations

Xiuting Wang, Yaqin Li, Ying Bai, Qi Li, Shuling Wang +5 more